RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6
about
sameAs
Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms.STRUBBELIG defines a receptor kinase-mediated signaling pathway regulating organ development in Arabidopsis.Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionMindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signalingHuman epicardial cell-conditioned medium contains HGF/IgG complexes that phosphorylate RYK and protect against vascular injury.Signalling through kinase-defective domains: the prevalence of atypical receptor-like kinases in plants.Eph/ephrin signaling: networks.Emerging mechanisms in morphogen-mediated axon guidance.Eph-dependent cell-cell adhesion and segregation in development and cancer.Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma.Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration.The direct activation of MIK, a germinal center kinase (GCK)-like kinase, by MARK, a maize atypical receptor kinase, suggests a new mechanism for signaling through kinase-dead receptors.Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.
P2860
Q30315828-BB27524E-E161-429B-9CDD-ECB6F65D65C5Q30488242-19B72F71-A0C6-4252-A225-54C9FD7BABADQ33863259-5D2373DA-DBA2-4A1A-AB21-EF22C84D1E8FQ33965278-13B8F008-87BF-4098-889C-15C4C360ECE4Q34211643-7DCB8C55-F66B-4A28-9F69-238A4A5F4107Q36048987-AFC365D9-6D78-4DB9-9BA8-2ECF6F170E2EQ36977146-8672A52B-734F-486D-A318-62FF19B2597AQ37087056-E29F2424-C3F2-4E0A-8FEF-3CD7B0C0FF40Q37586353-CF5EA926-866D-4241-87B6-EC92530092E1Q37971902-643B8E8E-2AB4-4A12-B903-4B1794B719FEQ39996613-9AE70A29-7DA1-44C2-BC0B-6C670368B1CFQ40410006-2817D8BD-9355-4CD9-9CCE-A8B8DB0742C4Q44579396-CDE762CE-9BEC-4FFD-A342-D1B26494B084Q55332428-C07EB6EB-FF33-4491-91F2-599096D283B1
P2860
RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
RYK, a catalytically inactive ...... ut does not interact with AF-6
@ast
RYK, a catalytically inactive ...... ut does not interact with AF-6
@en
RYK, a catalytically inactive ...... ut does not interact with AF-6
@nl
type
label
RYK, a catalytically inactive ...... ut does not interact with AF-6
@ast
RYK, a catalytically inactive ...... ut does not interact with AF-6
@en
RYK, a catalytically inactive ...... ut does not interact with AF-6
@nl
prefLabel
RYK, a catalytically inactive ...... ut does not interact with AF-6
@ast
RYK, a catalytically inactive ...... ut does not interact with AF-6
@en
RYK, a catalytically inactive ...... ut does not interact with AF-6
@nl
P2860
P356
P1476
RYK, a catalytically inactive ...... ut does not interact with AF-6
@en
P2093
Elisabeth Trivier
Trivadi S Ganesan
P2860
P304
P356
10.1074/JBC.M202486200
P407
P577
2002-06-21T00:00:00Z